r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

CS

Christopher Ryan Sullivan

Insider · Chief Financial Officer · AVTX

Christopher Ryan Sullivan files insider transactions with the SEC as a chief financial officer of Avalo Therapeutics (AVTX). We hold 8 disclosed purchases and sales filed since 11 June 2020, 2 of them in the last 90 days.

  • Files forAVTX
  • Disclosed buys and sells8 in all, 2 in the last 90 days
  • Last disclosure19 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 10 December 2021 — 18 August 2026Chief Financial Officer · Avalo Therapeutics (AVTX)49 Form 4 lines · source: SEC Form 4
  • Filed 10 June 2020 — 26 January 2021Interim CFO · Cerecor (CERC)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

52 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.